𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical trial opportunities in hemostasis and thrombosis: NHBLI State-of-the-science symposium

✍ Scribed by Douglas B. Cines; Morris A. Blajchman; Katherine A. High; James B. Bussel; for the State-of-the Science Symposium Hemostasis-Thrombosis Committee

Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
144 KB
Volume
87
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Drug delivery trends in clinical trials
Drug delivery trends in clinical trials and translational medicine: Challenges and opportunities in the delivery of nucleic acid-based therapeutics
✍ Long Xu; Thomas Anchordoquy πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 162 KB πŸ‘ 1 views

The ability to deliver nucleic acids (e.g., plasmid DNA, antisense oligonucleotides, siRNA) offers the potential to develop potent vaccines and novel therapeutics. However, nucleic acid-based therapeutics are still in their early stages as a new category of biologics. The efficacy of nucleic acids r

Advances in data assessment. Application
Advances in data assessment. Application to the etiology of nausea reported during chemotherapy, concerns about significance testing, and opportunities in clinical trials
✍ Gary R. Morrow; Peter M. Black; Deborah J. Dudgeon πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 728 KB

Typical inferential statistical procedures, such as the t-test and analysis of variance, compare differences in mean values of variables. This approach can sometimes obscure rather than illuminate research data. Here we present and discuss alternative data analytic techniques. Potential advantages o

Challenges and recommendations for advan
Challenges and recommendations for advancing the state-of-the-science of quality of life assessment in symptom management trials
✍ David R. Buchanan; Ann M. O'Mara; Joseph W. Kelaghan; Maria Sgambati; Worta McCa πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 161 KB

## Abstract Major findings are presented from a workshop on Quality of Life Assessment in Cancer Symptom Management Trials, sponsored by the National Cancer Institute. Data‐driven research reports focused on 3 topics, 1) the rationale and utility of health‐related quality of life (HRQOL) assessment